BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26904570)

  • 1. Prospective randomized study comparing concomitant chemoradiotherapy using weekly cisplatin & paclitaxel versus weekly cisplatin in locally advanced carcinoma cervix.
    Thakur P; Seam R; Gupta M; Gupta M
    Ann Transl Med; 2016 Feb; 4(3):48. PubMed ID: 26904570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin Chemoradiotherapy vs Radiotherapy in FIGO Stage IIIB Squamous Cell Carcinoma of the Uterine Cervix: A Randomized Clinical Trial.
    Shrivastava S; Mahantshetty U; Engineer R; Chopra S; Hawaldar R; Hande V; Kerkar RA; Maheshwari A; Shylasree TS; Ghosh J; Bajpai J; Gurram L; Gulia S; Gupta S;
    JAMA Oncol; 2018 Apr; 4(4):506-513. PubMed ID: 29423520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can pure accelerated radiotherapy given as six fractions weekly be an option in locally advanced carcinoma cervix: Results of a prospective randomized phase III trial.
    Sharma M; Revannasiddaiah S; Gupta M; Seam RK; Gupta MK; Rastogi M
    J Cancer Res Ther; 2016; 12(1):103-8. PubMed ID: 27072219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent Chemoradiotherapy in Locally Advanced Carcinoma of the Uterine Cervix Preliminary Results of Phases III Prospective Randomized Trial.
    Kim YS; Choi EK; Kim JH; Ahn SD; Lee SW; Kim JH; Kim YM; Kim YT; Mok JE; Nam JH
    Cancer Res Treat; 2002 Jun; 34(3):191-7. PubMed ID: 26680862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten years survival results of randomized study comparing weekly
    Nanda R; Katke A; Thejaswini B; Giri GV; Pawar Y; Manjula MV; Babu G
    Rep Pract Oncol Radiother; 2023; 28(3):322-331. PubMed ID: 37795405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External Beam Radiotherapy Interdigitated with High Dose Rate(HDR) Intracavitary Brachytherapy versus External Beam Radiotherapy followed by Sequential HDR Intracavitary Brachytherapy for Locally Advanced Carcinoma Cervix-Randomized Control Study.
    Gupta IJ; Ghosh A; Yadav J; Tuteja JS; Gupta R; Srivastava K; Verma M; Gupta S; Srivastava S; Bhatt MLB
    Asian Pac J Cancer Prev; 2023 Oct; 24(10):3441-3445. PubMed ID: 37898849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
    Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II/III Randomized Controlled Trial of Concomitant Hyperfractionated Radiotherapy plus Cetuximab (Anti-EGFR Antibody) or Chemotherapy in Locally Advanced Head and Neck Cancer.
    Al-Saleh K; El-Sherify M; Safwat R; Elbasmy A; Shete J; Hussein A; Nazeeh M; Bedair A
    Gulf J Oncolog; 2019 May; 1(30):6-12. PubMed ID: 31242976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Treatment Time on Chemoradiotherapy in Locally Advanced Cervical Carcinoma.
    Pathy S; Kumar L; Pandey RM; Upadhyay A; Roy S; Dadhwal V; Madan R; Chander S
    Asian Pac J Cancer Prev; 2015; 16(12):5075-9. PubMed ID: 26163644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma-the ESO-shanghai 1 trial protocol.
    Chen Y; Zhu Z; Zhao W; Li L; Ye J; Wu C; Tang H; Lin Q; Li J; Xia Y; Li Y; Zhou J; Zhao K
    Radiat Oncol; 2018 Feb; 13(1):33. PubMed ID: 29482649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized phase-III-trial of concurrent chemoradiation for locally advanced head and neck cancer comparing dose reduced radiotherapy with paclitaxel/cisplatin to standard radiotherapy with fluorouracil/cisplatin: The PacCis-trial.
    Fietkau R; Hecht M; Hofner B; Lubgan D; Iro H; Gefeller O; Rödel C; Hautmann MG; Kölbl O; Salay A; Rübe C; Melchior P; Breinl P; Krings W; Gripp S; Wollenberg B; Keerl R; Schreck U; Siekmeyer B; Grabenbauer GG; Balermpas P;
    Radiother Oncol; 2020 Mar; 144():209-217. PubMed ID: 32044419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weekly
    Katke A; Nanda R; Thejaswini B; Pasha T; Giri GV; Babu G; Pawar Y
    Rep Pract Oncol Radiother; 2021; 26(6):948-954. PubMed ID: 34992867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent Weekly versus Three Weekly Cisplatin with Radiotherapy in Locally Advanced Uterine Cervical Carcinoma.
    Hasan MR; Bari MA; Alam S; Sah GS
    JNMA J Nepal Med Assoc; 2018; 56(213):842-847. PubMed ID: 31065118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized Controlled Trial Comparing Clinical Outcomes and Toxicity of Lobaplatin- Versus Cisplatin-Based Concurrent Chemotherapy Plus Radiotherapy and High-Dose-Rate Brachytherapy for FIGO Stage II and III Cervical Cancer.
    Wang JQ; Wang T; Shi F; Yang YY; Su J; Chai YL; Liu Z
    Asian Pac J Cancer Prev; 2015; 16(14):5957-61. PubMed ID: 26320479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study.
    Gandhi AK; Sharma DN; Rath GK; Julka PK; Subramani V; Sharma S; Manigandan D; Laviraj MA; Kumar S; Thulkar S
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):542-8. PubMed ID: 24074927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer.
    Martínez-Monge R; Gaztañaga M; Aramendía JM; Cambeiro M; Arbea L; Espinós J; Aristu JJ; Jurado M
    Int J Gynecol Cancer; 2010 Jan; 20(1):133-40. PubMed ID: 20130514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary results of a randomized trial comparing monthly 5-flourouracil and cisplatin to weekly cisplatin alone combined with concurrent radiotherapy for locally advanced cervical cancer.
    Kim YS; Shin SS; Choi EK; Kim JH; Ahn SD; Lee SW; Park HJ; Kim YT; Mok JE; Nam JH
    Cancer Res Treat; 2005 Feb; 37(1):37-43. PubMed ID: 19956508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Results of a Phase II Trial of Concomitant Cisplatin-Paclitaxel Chemoradiation in Locally Advanced Cervical Cancer.
    Martínez-Fernández MI; Legaspi Folgueira J; Valtueña Peydró G; Cambeiro M; Espinós J; Aramendía JM; Minguez-Milio JA; Martínez-Monge R
    Int J Gynecol Cancer; 2016 Jul; 26(6):1162-8. PubMed ID: 27327153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of six fractions per week chemoradiation versus five fractions per week of conventional chemoradiation in carcinoma cervix: A prospective controlled study.
    Kumar D; Pradhan S; Choudhary S; Aggarwal LM; Das A; Sarangdhar S; Kaser P; Dewangan S
    J Cancer Res Ther; 2019; 15(6):1296-1303. PubMed ID: 31898663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weekly cisplatin plus external beam radiotherapy and high dose rate brachytherapy in patients with locally advanced carcinoma of the cervix.
    Souhami L; Seymour R; Roman TN; Stanimir GW; Trudeau M; Clark BG; Freeman CR
    Int J Radiat Oncol Biol Phys; 1993 Nov; 27(4):871-8. PubMed ID: 8244817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.